Buy Stocks Easy | About Us
January 27, 2022
Buy Stocks Easy | Online Stocks

IDRA


Buy Idera Pharmaceuticals, Inc. Stock (symbol: IDRA) Easy Online

Company Name: Idera Pharmaceuticals, Inc.

Symbol: IDRA

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

IPO: 2000

IDRA Current Share Price

Today's IDRA ( Idera Pharmaceuticals, Inc. ) opening price: $1.5300

Yesterday's IDRA ( Idera Pharmaceuticals, Inc. ) closing price: $1.5200

Idera Pharmaceuticals, Inc. Stock ( symbol: IDRA ) Price Chart since IPO (2000):

12 Months Idera Pharmaceuticals, Inc. Stock ( symbol: IDRA ) Price Chart

Popular Questions about Idera Pharmaceuticals, Inc. Public Stock ( IDRA )

A: Idera Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is IDRA

A: Idera Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2000

A: Idera Pharmaceuticals, Inc.'s stock (IDRA symbol) price at ther IPO (initial Public Offering) was $1.5300

Q: Is IDRA stock worth buying at the moment?

A: The IDRA stock performance since 2019 are rather disappointing. If you had bought 1 share of Idera Pharmaceuticals, Inc. stock (symbol: IDRA) at the beginning of 2019, at the opening share price of $2.5300, you would be left with exactly $1.5300 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Idera Pharmaceuticals, Inc. Stock Easy Online

Idera Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Idera Pharmaceuticals, Inc. Stock Price Yesterday



 


Idera Pharmaceuticals, Inc. Stock Price – Last Week




 


Idera Pharmaceuticals, Inc. Stock Price – Last Month




 


Idera Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932411/0/en/Idera-Pharmaceuticals-Announces-New-U-S-Patent-For-Tilsotolimod-Through-September-2037.html
                            

                                
Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037

                                
                                
EXTON, Pa., Oct.  21, 2019  (GLOBE NEWSWIRE) -- Idera Pharmaceutica...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/30/1922399/0/en/Idera-Pharmaceuticals-Announces-Initiation-of-the-ILLUMINATE-206-Trial-Evaluating-Tilsotolimod-in-Combination-with-Nivolumab-and-Ipilimumab-for-the-Treatment-of-Solid-Tumors.html
                            

                                
Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors

                                
                                
EXTON, Pa., Sept.  30, 2019  (GLOBE NEWSWIRE) -- Idera Pharmaceutic...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/30/1909222/0/en/Idera-Pharmaceuticals-to-Present-at-the-Baird-2019-Global-Healthcare-Conference.html
                            

                                
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference

                                
                                
EXTON, Pa., Aug.  30, 2019  (GLOBE NEWSWIRE) -- Idera Pharmaceutica...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4283403-idera-pharmaceuticals-inc-idra-ceo-vincent-milano-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
Idera Pharmaceuticals, Inc. (IDRA) CEO Vincent Milano on Q2 2019 Results - Earnings Call Transcript

                                
                                
Idera Pharmaceuticals, Inc. (IDRA) CEO Vincent Milano on Q2 2019 Re...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/461301/idera-pharmaceuticals-idra-reports-q2-loss-tops-revenue-estimates
                            

                                
Idera Pharmaceuticals (IDRA) Reports Q2 Loss, Tops Revenue Estimates

                                
                                
Idera (IDRA) delivered earnings and revenue surprises of 7.14% and ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/412604/idera-pharmaceuticals-inc-idra-shares-march-higher-can-it-continue
                            

                                
Idera Pharmaceuticals, Inc. (IDRA) Shares March Higher, Can It Continue?

                                
                                
As of late, it has definitely been a great time to be an investor i...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/408218/idera-pharmaceuticals-idra-reports-q1-loss-lags-revenue-estimates
                            

                                
Idera Pharmaceuticals (IDRA) Reports Q1 Loss, Lags Revenue Estimates

                                
                                
Idera (IDRA) delivered earnings and revenue surprises of 13.04% and...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932411/0/en/Idera-Pharmaceuticals-Announces-New-U-S-Patent-For-Tilsotolimod-Through-September-2037.html
                            

                                
Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037

                                
                                
EXTON, Pa., Oct.  21, 2019  (GLOBE NEWSWIRE) -- Idera Pharmaceutica...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/30/1922399/0/en/Idera-Pharmaceuticals-Announces-Initiation-of-the-ILLUMINATE-206-Trial-Evaluating-Tilsotolimod-in-Combination-with-Nivolumab-and-Ipilimumab-for-the-Treatment-of-Solid-Tumors.html
                            

                                
Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors

                                
                                
EXTON, Pa., Sept.  30, 2019  (GLOBE NEWSWIRE) -- Idera Pharmaceutic...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/30/1909222/0/en/Idera-Pharmaceuticals-to-Present-at-the-Baird-2019-Global-Healthcare-Conference.html
                            

                                
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference

                                
                                
EXTON, Pa., Aug.  30, 2019  (GLOBE NEWSWIRE) -- Idera Pharmaceutica...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4283403-idera-pharmaceuticals-inc-idra-ceo-vincent-milano-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
Idera Pharmaceuticals, Inc. (IDRA) CEO Vincent Milano on Q2 2019 Results - Earnings Call Transcript

                                
                                
Idera Pharmaceuticals, Inc. (IDRA) CEO Vincent Milano on Q2 2019 Re...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/461301/idera-pharmaceuticals-idra-reports-q2-loss-tops-revenue-estimates
                            

                                
Idera Pharmaceuticals (IDRA) Reports Q2 Loss, Tops Revenue Estimates

                                
                                
Idera (IDRA) delivered earnings and revenue surprises of 7.14% and ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/412604/idera-pharmaceuticals-inc-idra-shares-march-higher-can-it-continue
                            

                                
Idera Pharmaceuticals, Inc. (IDRA) Shares March Higher, Can It Continue?

                                
                                
As of late, it has definitely been a great time to be an investor i...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/408218/idera-pharmaceuticals-idra-reports-q1-loss-lags-revenue-estimates
                            

                                
Idera Pharmaceuticals (IDRA) Reports Q1 Loss, Lags Revenue Estimates

                                
                                
Idera (IDRA) delivered earnings and revenue surprises of 13.04% and...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.